Health
UK closer to human problem trials of potential COVID-19 vaccines that infect volunteers – Republic World – Republic World
Preliminary work for trials, which aims to determine the efficacy of a vaccine candidate is being carried out by UK’s Open Orphan plc (ORPH) hVIVO.
On October 15, the UK’s biotech agency announced that its “Human problem” trials of potential COVID-19 vaccines could become a reality where volunteers are deliberately infected with SARS-CoV-2 as the pharmaceutical firm signed a contract with the UK’s government to procure the strains of the virus. Preliminary work for the trials, which aims to determine the efficacy of a vaccine candidate is being carried out by a unit of pharmaceutical service company Open Orphan plc (ORPH) hVIVO.
The model …
-
Noosa News24 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Noosa News21 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General19 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Business22 hours agoInvested in IAG shares? Here are the key dates for FY26